BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12117076)

  • 1. Statistical comparison of consumer drug expenditures and discretionary purchases to assess drug affordability.
    Lee JA; McKercher PL
    Clin Ther; 2002 Jun; 24(6):1003-16; discussion 1002. PubMed ID: 12117076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Income class and pharmaceutical expenditure in Canada: 1964-1990.
    Lexchin J
    Can J Public Health; 1996; 87(1):46-50. PubMed ID: 8991744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial Burden and Out-of-Pocket Expenditures for Mental Health Across Different Socioeconomic Groups: Results from HealthCare for Communities.
    Ringel JS; Sturm R
    J Ment Health Policy Econ; 2001 Sep; 4(3):141-150. PubMed ID: 11967474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
    Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
    Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic burden of prescription drug use among elderly patients in Ponce, Puerto Rico.
    López-Negrón L; Monsanto-Planadeball HA
    P R Health Sci J; 2006 Jun; 25(2):149-53. PubMed ID: 17203713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How much 'skin in the game' do medicare beneficiaries have? The increasing financial burden of health care spending, 1997-2003.
    Neuman P; Cubanski J; Desmond KA; Rice TH
    Health Aff (Millwood); 2007; 26(6):1692-701. PubMed ID: 17978388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating Willingness-to-Pay for health insurance among rural poor in India by reference to Engel's law.
    Binnendijk E; Dror DM; Gerelle E; Koren R
    Soc Sci Med; 2013 Jan; 76(1):67-73. PubMed ID: 23157931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the Affordability of Prescription Medications for People with Chronic Respiratory Disease. An Official American Thoracic Society Policy Statement.
    Patel MR; Press VG; Gerald LB; Barnes T; Blake K; Brown LK; Costello RW; Crim C; Forshag M; Gershon AS; Goss CH; Han MK; Lee TA; Sweet S; Gerald JK
    Am J Respir Crit Care Med; 2018 Dec; 198(11):1367-1374. PubMed ID: 30601674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in estimated Medicare prescription drug plan costs and affordability for beneficiaries living in different states.
    Davis MM; Patel MS; Halasyamani LK
    J Gen Intern Med; 2007 Feb; 22(2):257-63. PubMed ID: 17356996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of health care financing on family budgets.
    Rasell E; Bernstein J; Tang K
    Int J Health Serv; 1994; 24(4):691-714. PubMed ID: 7896470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Out-of-pocket health expenses for Medicaid and other poor and near-poor persons in 1980.
    Howell E; Corder L; Dobson A
    Natl Med Care Util Expend Surv B; 1985 Aug; (4):1-52. PubMed ID: 10313450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement.
    Yala SM; Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF
    BMC Health Serv Res; 2014 Dec; 14():665. PubMed ID: 25526892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Out-of-pocket health care costs among older Americans.
    Crystal S; Johnson RW; Harman J; Sambamoorthi U; Kumar R
    J Gerontol B Psychol Sci Soc Sci; 2000 Jan; 55(1):S51-62. PubMed ID: 10728130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription drug use among elderly and nonelderly families.
    McKercher PL; Taylor SD; Lee JA; Chao J; Kumar RN
    J Manag Care Pharm; 2003; 9(1):19-28. PubMed ID: 14613358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Out-of-pocket spending on drugs and pharmaceutical products and cost-related prescription non-adherence among Canadians with chronic disease.
    Hennessy D; Sanmartin C; Ronksley P; Weaver R; Campbell D; Manns B; Tonelli M; Hemmelgarn B
    Health Rep; 2016 Jun; 27(6):3-8. PubMed ID: 27305075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.
    Saleh SS; Weller W; Hannan E
    J Health Hum Serv Adm; 2007; 30(1):50-74. PubMed ID: 17557696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transferring the financial risks of pharmaceutical benefits from a large health care provider in Argentina to a consortium of pharmaceutical companies.
    Cervellino JC; Corazza SB; Bignone IM; Fligman MD; Figueroa S; Roldán R; Morici P; Diez RA
    Rev Panam Salud Publica; 2003 Apr; 13(4):203-13. PubMed ID: 12804149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing Medicare beneficiaries' willingness-to-pay for medication therapy management services.
    Woelfel JA; Carr-Lopez SM; Delos Santos M; Bui A; Patel RA; Walberg MP; Galal SM
    Consult Pharm; 2014 Feb; 29(2):104-9. PubMed ID: 24513420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the Medicare modernization act on low-income persons.
    Havrda DE; Omundsen BA; Bender W; Kirkpatrick MA
    Ann Intern Med; 2005 Oct; 143(8):600-8. PubMed ID: 16230727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.